Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Receivables data on record, last reported at $183.5 million in Q4 2025.

  • For Q4 2025, Receivables rose 12.12% year-over-year to $183.5 million; the TTM value through Dec 2025 reached $183.5 million, up 12.12%, while the annual FY2025 figure was $183.5 million, 12.12% up from the prior year.
  • Receivables reached $183.5 million in Q4 2025 per CLBT's latest filing, up from $163.7 million in the prior quarter.
  • Across five years, Receivables topped out at $183.5 million in Q4 2025 and bottomed at $67.7 million in Q4 2021.
  • Average Receivables over 5 years is $148.3 million, with a median of $163.7 million recorded in 2024.
  • Peak YoY movement for Receivables: surged 136.7% in 2022, then decreased 1.65% in 2024.
  • A 5-year view of Receivables shows it stood at $67.7 million in 2021, then soared by 136.7% to $160.3 million in 2022, then grew by 3.84% to $166.4 million in 2023, then fell by 1.65% to $163.7 million in 2024, then increased by 12.12% to $183.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $183.5 million in Q4 2025, $163.7 million in Q4 2024, and $166.4 million in Q4 2023.